Efficacy and safety of evenamide, a glutamate modulator, added to a second-generation antipsychotic in inadequately/poorly responding patients with chronic schizophrenia: Results from a randomized, double-blind, placebo-controlled, phase 3, international clinical trial.

Autor: Anand R; Anand Pharma Consulting (APC), St. Moritz, Switzerland., Turolla A; Newron Pharmaceuticals SpA, Bresso, Italy., Chinellato G; Newron Pharmaceuticals SpA, Bresso, Italy. Electronic address: giovanni.chinellato@newron.com., Sansi F; Newron Pharmaceuticals SpA, Bresso, Italy., Roy A; CliniRx Research Pvt Ltd, New Delhi, India., Hartman R; NeurWrite LLC, Morristown, NJ, USA.

Publikováno v: Neuropharmacology [Neuropharmacology] 2024 Dec 19; Vol. 266, pp. 110275. Date of Electronic Publication: 2024 Dec 19.

Achievement of clinically meaningful response and remission in treatment-resistant schizophrenia patients: results from a long-term international study with evenamide add-on

Autor: Anand, R. ¹, Turolla, A. ², Chinellato, G. ², Giuliani, R. ², Sansi, F. ², Hartman, R. ³

Publikováno v: In Neuroscience Applied 2024 3 Supplement 2

INFLUENCE OF A SET OF VARIABLES ON A BOOLEAN FUNCTION.

Autor: BISWAS, ANIRUDDHA, SARKAR, PALASH

Publikováno v: SIAM Journal on Discrete Mathematics; 2023, Vol. 37 Issue 3, p2148-2171, 24p

The appropriateness of, and compliance with, telephone triage decisions: a systematic review and narrative synthesis.

Autor: Blank, Lindsay, Coster, Joanne, O'cathain, Alicia, Knowles, Emma, Tosh, Jonathan, Turner, Janette, Nicholl, Jon

Publikováno v: Journal of Advanced Nursing (John Wiley & Sons, Inc.); Dec2012, Vol. 68 Issue 12, p2610-2621, 0p, 1 Diagram, 2 Charts